Member Info for EIE01

In today’s finance section of the Daily Mail article on the price of Palladium and highlighting the recent significant price increase.

I read it in the paper, so afraid no link.

The bottom was in the 20s

Bridges, I don’t disagree, but don’t want to be accused of purely ramping.

We both have a very similar holding in Clon.

Potentially looking at significant returns.

Adam, no way does the current price reflect confirmation of ratification.

I am expecting a minimum of 2.5p MINIMUM!!

I would also suggest upon ratification news there is the distinct probability that Clontarf will also farm out news, adding a significant boost to the price.

I can now, but not at 1.10 offer

Tried buying on that fall, nothing doing always NT

Like you I’m in CLON with a substantial holding.

Think December is potentially a very rewarding month for both.

Bridges I believe Icarus is referring to your use of ‘100k’ in respect of the market cap.

We are talking millions, not k,

Yes the question and answer were in the interview about two weeks ago.

If anyone hasn’t seen it, then I’d imagine you have been invested in EUA less than two weeks.

Very good interview, and very much worth watching.

I also thought that Dmitry gave the impression that now was the time for a return on his initial investment back in 2008.

Just listened to the Dmitry interview again and I’d advise any potential investors or doubters to also.

Highlights for me were the following:

Offers plural
Benchmark against recent market transactions
15m Oz (potentiality 40m Oz mentioned)
Two blue chip investment banks working on a no fee basis (Dmitry highlighted why do this)
Eurasia one of the last remaining companies with significant exposure to Palladium.
Dmitry invested initially GBP 1m at 5p
Expects the banks to bring serious offers to the table
Cash positive
Dividend policy options under review
Open pit, low market costs

No problem.

I guarantee it wasn’t a stop loss hit, FACT, simply because that was my sale.

I needed to sell part of my holding in EUA to cover a balance due.

I subsequently bought back, but had to buy in four transactions at a smaller volume.

In my opinion there is very little stock available.

Bridges - I read a comment of yours the other day, and noticed we both hold a very similar amount shares in Clon.

Tremendous upside here.

I notice Align stating they have been buying and remain confident of a settlement.

Due to dilution your price target has fallen from 30p to now start unloading at 1.5p, that makes no sense.

Dilution wouldn’t in anyway account for that change in price target.

Surely Clon won’t be one of the 16 companies applying, as the company are in discussions as to the awarding of revised coordinates.

I may have this wrong as I’m not a particularly close follower of Clontarf. My understanding was that Clon had an agreement for Tano 2A and following the Sep RNS all legal issues were believed to be resolved, thus allowing for the submission of the PA. Now Clon would not have said this without the approval of the GNPC. Has something changed, or are the reports misleading, wrong? Either way I expect an update next week. My last point was I seem to recall that Clon maybe offered alternative coordinates to Tano 2A, maybe this is still the case?

“Salinity measurements of the flowback fluid indicate that connectivity to the reservoir remains limited, as expected, at this early stage. Total clean up fluid returned (net of diesel for freeze protection and any other fluids introduced as part of the current operation) since commencement of flowback on 12th June is 820 barrels (interpreted as 100% stimulation fluid). Total fluid returned for the entire flowback operation, including last year, is now 6,353 barrels or 23% of the frac fluid injected vs a target percentage return of at least 30%.”

If no RNS released tomorrow regarding why additional equity is being raised, I certainly wouldn’t assume that’s a negative. If funding was required to ensure a going concern status, it would have or will be announced tomorrow. Alternatively if funding is linked to something altogether different, who knows, the company maybe restricted to terms of a NDA.